A Study to Evaluate the Efficacy and Safety of CREZET Tablet
NCT05889143 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000
Last updated 2025-08-24
Summary
This observation study is to evaluate blood lipid-lowering effects and liver/renal safety, changes in HbA1c and FPG in patients with dyslipidemia who administered CREZET tablets for 24 weeks.
Conditions
- Dyslipidemias
Interventions
- DRUG
-
Ezetimibe/Rosuvastatin
Patient treated with Crezet Tablet
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Principal Investigators
-
JunYoung Park · Daewoong Pharma
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-24
- Primary Completion
- 2024-12-31
- Completion
- 2026-03-01
Countries
- South Korea
Study Locations
More Related Trials
-
A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276
NCT01493856 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
NCT02859480 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
NCT00240305 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome
NCT04056169 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
NCT02445352 ·Status: COMPLETED ·Phase: PHASE3
-
Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION
NCT00526721 ·Status: COMPLETED
-
Vascular and Metabolic Effects of Rosuvastatin
NCT01660919 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Crestor on Lipoprotein Metabolism in Humans
NCT00214617 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT03175835 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia
NCT01414803 ·Status: COMPLETED ·Phase: PHASE4
-
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
NCT00335699 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline
NCT03903029 ·Status: COMPLETED
-
Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study
NCT07084246 ·Status: ACTIVE_NOT_RECRUITING
-
Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
NCT03597412 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.
NCT01982461 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers
NCT01831479 ·Status: COMPLETED ·Phase: PHASE1
-
to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers
NCT02289430 ·Status: COMPLETED ·Phase: PHASE1
-
High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
NCT03403556 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
NCT00240266 ·Status: COMPLETED ·Phase: PHASE3
-
12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
NCT00525824 ·Status: COMPLETED ·Phase: PHASE3
-
Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )
NCT00526708 ·Status: COMPLETED
-
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
NCT06293261 ·Status: COMPLETED
-
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
NCT03571087 ·Status: COMPLETED ·Phase: PHASE3
-
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
NCT00688454 ·Status: COMPLETED
-
Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
NCT03446261 ·Status: COMPLETED ·Phase: PHASE4